<DOC>
	<DOCNO>NCT00176982</DOCNO>
	<brief_summary>Alopecia areata autoimmune condition result hair loss complete baldness ( alopecia totalis ) . Published evidence say mediate T-lymphocytes . Plaquenil anti-inflammatory drug approve FDA malaria , lupus erythematosus , rheumatoid arthritis . It effect T-lymphocyte mediate inflammation , make logical choice treatment trail alopecia areata .</brief_summary>
	<brief_title>Plaquenil Alopecia Areata , Alopecia Totalis</brief_title>
	<detailed_description>Alopecia areata high prevalence autoimmune disease significant consequence . Alopecia areata tissue restrict autoimmune disease direct hair follicle , result hair loss . Patients frequently suffer severe psychiatric consequence . This especially true girl young woman become bald . The incidence alopecia areata USA ( Minnesota 20.2 per 100,000 person-years lifetime risk approximately 1.7 % . There significant gender difference . The disease often chronic remitting , relapse course . Although responds immunosuppression , generalize immunosuppression significant morbidity treatment frequently frustrate successful . New treatment option essential . With evidence alopecia areata T-lymphocyte mediate autoimmune condition become model system study pathogenesis treatment T-cell mediate autoimmunity model host additional T-cell mediate autoimmune condition .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>1 . Severe alopecia areata : &gt; 75 % loss scalp hair alopecia areata totalis : 100 % loss scalp hair without loss body hair ( alopecia universalis ) 2 . Group I ( 8 subject ) : Duration disease less 1 year 3 . Group II ( 8 subject ) : Duration disease great 1 year 4 . At least 18 year old 5 . Able give consent . 1 . Coexisting significant systemic disease would increase risk hydroxychloroquine ( e.g . renal disease , liver disease , alcoholism , anemia , blood dyscrasia , psoriasis , porphyria ) 2 . Systemic immunosuppressive therapy within 3 week ( e.g . prednisone , cyclosporin , azathioprine ) 3 . Immunosuppressive condition ( e.g . HIV infection , cancer immunotherapy genetic immunodeficiency 4 . Medications potential interaction hydroxychloroquine ( e.g . liver toxin , bone marrow toxin ) 5 . Pregnancy , breast feeding 6 . Women child bear potential able willing use two method contraception least one hypersensitivity 4aminoquinolone compound ( chloroquine hydroxychloroquine ) 9 . Glucose6phosphate deficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>treatment alopecia areata</keyword>
</DOC>